Cargando…
Irreversible fatal contrast-induced encephalopathy: a case report
BACKGROUND: Contrast-induced encephalopathy (CIE) is a well-known complication of iodinated contrast agents during angiography and vascular interventions. It can manifest as hemiparesis, cortical blindness, speech changes, Parkinsonism, confusion, seizure, and coma. Most of the reported CIE cases ha...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437917/ https://www.ncbi.nlm.nih.gov/pubmed/30922249 http://dx.doi.org/10.1186/s12883-019-1279-5 |
_version_ | 1783407018359390208 |
---|---|
author | Zhao, Wei Zhang, Jinping Song, Yun Sun, Lili Zheng, Meimei Yin, Hao Zhang, Jun Wang, Wei Han, Ju |
author_facet | Zhao, Wei Zhang, Jinping Song, Yun Sun, Lili Zheng, Meimei Yin, Hao Zhang, Jun Wang, Wei Han, Ju |
author_sort | Zhao, Wei |
collection | PubMed |
description | BACKGROUND: Contrast-induced encephalopathy (CIE) is a well-known complication of iodinated contrast agents during angiography and vascular interventions. It can manifest as hemiparesis, cortical blindness, speech changes, Parkinsonism, confusion, seizure, and coma. Most of the reported CIE cases have been transient and reversible. Irreversible fatal CIE cases have been rarely reported. All the fatal CIE cases reported involved the use of ionic high osmolar contrast agents. Here, we document a heretofore unreported fatal CIE after digital subtraction angiography (DSA) using iopamidol, which is a type of non-ionic monomer low osmolar contrast agent. CASE PRESENTATION: A 71-year-old woman was admitted to our Department of Neurology for tinnitus in the head. The cerebral magnetic resonance angiography (MRA) detected atherosclerotic cerebral arteries and bilateral stenosis of the middle cerebral arteries. The patient underwent DSA for further diagnostic work-up. The total amount of iopamidol used during the procedure was 110 ml. The patient experienced headache during the procedure, followed by dizziness with nausea and vomiting. Despite treatment with anti-oedema medications, her clinical status was gradually deteriorating and ended up with deep coma due to irreversible cerebral oedema which was confirmed by cerebral computed tomography (CT). Finally, the patient died 56 days after the procedure due to irreversible fatal cerebral oedema. CONCLUSIONS: This report documents that iopamidol-induced encephalopathy may not always have a benign outcome and can result in irreversible fatal cerebral oedema. |
format | Online Article Text |
id | pubmed-6437917 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64379172019-04-08 Irreversible fatal contrast-induced encephalopathy: a case report Zhao, Wei Zhang, Jinping Song, Yun Sun, Lili Zheng, Meimei Yin, Hao Zhang, Jun Wang, Wei Han, Ju BMC Neurol Case Report BACKGROUND: Contrast-induced encephalopathy (CIE) is a well-known complication of iodinated contrast agents during angiography and vascular interventions. It can manifest as hemiparesis, cortical blindness, speech changes, Parkinsonism, confusion, seizure, and coma. Most of the reported CIE cases have been transient and reversible. Irreversible fatal CIE cases have been rarely reported. All the fatal CIE cases reported involved the use of ionic high osmolar contrast agents. Here, we document a heretofore unreported fatal CIE after digital subtraction angiography (DSA) using iopamidol, which is a type of non-ionic monomer low osmolar contrast agent. CASE PRESENTATION: A 71-year-old woman was admitted to our Department of Neurology for tinnitus in the head. The cerebral magnetic resonance angiography (MRA) detected atherosclerotic cerebral arteries and bilateral stenosis of the middle cerebral arteries. The patient underwent DSA for further diagnostic work-up. The total amount of iopamidol used during the procedure was 110 ml. The patient experienced headache during the procedure, followed by dizziness with nausea and vomiting. Despite treatment with anti-oedema medications, her clinical status was gradually deteriorating and ended up with deep coma due to irreversible cerebral oedema which was confirmed by cerebral computed tomography (CT). Finally, the patient died 56 days after the procedure due to irreversible fatal cerebral oedema. CONCLUSIONS: This report documents that iopamidol-induced encephalopathy may not always have a benign outcome and can result in irreversible fatal cerebral oedema. BioMed Central 2019-03-28 /pmc/articles/PMC6437917/ /pubmed/30922249 http://dx.doi.org/10.1186/s12883-019-1279-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Zhao, Wei Zhang, Jinping Song, Yun Sun, Lili Zheng, Meimei Yin, Hao Zhang, Jun Wang, Wei Han, Ju Irreversible fatal contrast-induced encephalopathy: a case report |
title | Irreversible fatal contrast-induced encephalopathy: a case report |
title_full | Irreversible fatal contrast-induced encephalopathy: a case report |
title_fullStr | Irreversible fatal contrast-induced encephalopathy: a case report |
title_full_unstemmed | Irreversible fatal contrast-induced encephalopathy: a case report |
title_short | Irreversible fatal contrast-induced encephalopathy: a case report |
title_sort | irreversible fatal contrast-induced encephalopathy: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437917/ https://www.ncbi.nlm.nih.gov/pubmed/30922249 http://dx.doi.org/10.1186/s12883-019-1279-5 |
work_keys_str_mv | AT zhaowei irreversiblefatalcontrastinducedencephalopathyacasereport AT zhangjinping irreversiblefatalcontrastinducedencephalopathyacasereport AT songyun irreversiblefatalcontrastinducedencephalopathyacasereport AT sunlili irreversiblefatalcontrastinducedencephalopathyacasereport AT zhengmeimei irreversiblefatalcontrastinducedencephalopathyacasereport AT yinhao irreversiblefatalcontrastinducedencephalopathyacasereport AT zhangjun irreversiblefatalcontrastinducedencephalopathyacasereport AT wangwei irreversiblefatalcontrastinducedencephalopathyacasereport AT hanju irreversiblefatalcontrastinducedencephalopathyacasereport |